The impact of antimicrobial resistance on health and economic outcomes.
about
Antibiotic resistance in primary care in Austria - a systematic review of scientific and grey literatureMortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studiesBiochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitorSynergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA)Targeting an Essential GTPase Obg for the Development of Broad-Spectrum AntibioticsAntibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia.Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia.Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control studyAttributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.Colonisation of antibiotic resistant bacteria in a cohort of HIV infected children in Ghana.Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001Risk factors for antibiotic-resistant E. coli in children in a rural area.How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizationsEstimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitalsAntimicrobial drug use in food-producing animals and associated human health risks: what, and how strong, is the evidence?Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalizationThe appropriateness of prescribing antibiotics in the community in Europe: study design.Factors associated with variation in estimates of the cost of resistant infectionsMolecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural VietnamMultidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community.Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.Human enteroviruses are not the cause of neurological impairments in children at the Korle-Bu Teaching HospitalUsing interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusImpact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomesAntimicrobial stewardship - can we afford to do without it?The determinants of the antibiotic resistance process.Is antibiotic resistance a problem? A practical guide for hospital clinicians.Prevalence and resistance patterns of commensal S. aureus in community-dwelling GP patients and socio-demographic associations. A cross-sectional study in the framework of the APRES-project in AustriaAntibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European CountriesConfronting bacterial resistance in healthcare settings: a crucial role for microbiologists.Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.Reference group choice and antibiotic resistance outcomes.Antimicrobial resistance in Neisseria gonorrhoeae in China: a meta-analysis
P2860
Q26996633-037A0CF0-200B-42B2-B828-8DE895A39A93Q28068844-77BB771B-D8FA-4266-9235-46E2F0794634Q28486539-C4608B1B-5977-4D2F-95A1-3A9587C00E24Q28487249-1BC13A68-780A-4F71-A678-82DCBC88E424Q28553171-4B4AD167-F117-453B-8900-CD9ECC4ECCFCQ31096335-A6D0ABBC-131E-4A96-9575-D18DD0E277E8Q33290348-17C549AA-27B5-4C2A-974F-B080706AF2CFQ33412202-440A8C7E-65BC-452C-9237-76D989AB3C2CQ33429259-4AF3EA39-7EC2-4BC2-812C-DAC05FE8C0A6Q33559105-D77C596F-89EE-4E67-A073-96F972E7C6B8Q33585756-A3B0AF94-01E5-4B57-ADCA-AA137EC6EC8AQ33654539-1DD7AA46-0CE8-4E0B-B302-044593595E8CQ33737692-7B64D947-F65F-4765-A21B-F8DFFDDB6586Q33759333-D7EFB8B2-660B-4E5A-8C4D-72AEDC5FCBE7Q33842265-7B20B229-4807-4A0E-9962-2B85A41DE900Q33870110-1F7E36F6-92B1-4EC7-A72F-5A3ABF5C3B02Q33877838-28E014ED-08C3-4F0B-82B5-E00E9597AF2AQ33883695-2B3ECA05-3525-4BC2-B84A-2E767513EC64Q34059751-78EE77CD-1BA9-45BC-B8AD-FCDD5B885600Q34077002-43ECC873-153B-42CB-A7AC-771D1C78E025Q34143675-43A33969-8B6A-4742-8A6D-7D50F52B98DDQ34150900-BD37BA8F-82A2-492E-9B98-7C89ACACB5A3Q34237433-AE6B65D9-1C94-4712-B18A-90A722C98857Q34301559-7A196350-7715-4C83-A47D-C7EA3AFC59CAQ34446914-82DBF9C4-6BB9-4928-BCFD-D05A717965C7Q34451829-127E220D-52A2-47B7-8C43-5B220026117CQ34510547-8E1E0840-57BA-4073-B878-8DE45FC08FCEQ34563993-D50A3828-500F-4637-A4D6-8804C6AC7315Q34680578-A5323DBD-5B12-4B3E-A0CD-E576C5ABD768Q34766191-88C03182-F820-4522-8C56-807D02D5125EQ35023684-22AEFDEF-07DE-4B30-BB33-021B29E81759Q35026542-8324BFDA-9F52-4690-9FDD-EC4E1F1B49D7Q35523222-AA86074D-523E-4223-A1C3-857F8BD3D973Q35633630-0E4708F1-12EB-4EA5-B392-3EB1B72BB682Q35742441-D47CACF2-089F-412D-AAE7-DC1DD4A89E06Q35745242-DF82A0CC-878E-40A5-821F-7F465176CCFFQ35806150-BF717880-633C-464C-91FA-261883DF3D14Q35876393-D19A6C60-C9A5-4A82-BC4A-28B7D4D361F1Q35880537-5B201765-B564-4CCA-BCD0-EAEE0C278967Q35945575-3F9F8A3D-CA81-4DDE-9244-B80F946B98F7
P2860
The impact of antimicrobial resistance on health and economic outcomes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The impact of antimicrobial resistance on health and economic outcomes.
@ast
The impact of antimicrobial resistance on health and economic outcomes.
@en
type
label
The impact of antimicrobial resistance on health and economic outcomes.
@ast
The impact of antimicrobial resistance on health and economic outcomes.
@en
prefLabel
The impact of antimicrobial resistance on health and economic outcomes.
@ast
The impact of antimicrobial resistance on health and economic outcomes.
@en
P356
P1476
The impact of antimicrobial resistance on health and economic outcomes.
@en
P2093
Sara E Cosgrove
Yehuda Carmeli
P304
P356
10.1086/375081
P407
P577
2003-05-16T00:00:00Z